| Literature DB >> 10656357 |
H A Hopkins1, R L Sinkowitz-Cochran, B A Rudin, H L Keyserling, W R Jarvis.
Abstract
Across-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. AR patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10656357 DOI： 10.1086/501698
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN： 0899-823X Impact factor: 3.254